BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 35077831)

  • 21. AKT2 identified as a potential target of mir-29a-3p via microRNA profiling of patients with high proliferation lacrimal gland adenoid cystic carcinoma.
    Zhao J; Liu X; Lin J; Jiang M; Xu F; Zhang C; Tang Q; Zhu L; Dong L; Lin T
    Exp Eye Res; 2022 Jun; 219():109067. PubMed ID: 35398208
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification of deregulated miRNAs and their targets in hepatitis B virus-associated hepatocellular carcinoma.
    Wang W; Zhao LJ; Tan YX; Ren H; Qi ZT
    World J Gastroenterol; 2012 Oct; 18(38):5442-53. PubMed ID: 23082062
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comprehensive analysis of the differential expression profile of microRNAs in missed abortion.
    Tian QX; Xia SH; Wu YH; Zhang JH; Wang LY; Zhu WP
    Kaohsiung J Med Sci; 2020 Feb; 36(2):114-121. PubMed ID: 31688986
    [TBL] [Abstract][Full Text] [Related]  

  • 24. MicroRNA Expression in Formalin-Fixed, Paraffin-Embedded Samples of Canine Cutaneous and Oral Melanoma by RT-qPCR.
    Zamarian V; Catozzi C; Ressel L; Finotello R; Ceciliani F; Vilafranca M; Altimira J; Lecchi C
    Vet Pathol; 2019 Nov; 56(6):848-855. PubMed ID: 31526125
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Micro RNA Transcriptome Profile in Canine Oral Melanoma.
    Rahman MM; Lai YC; Husna AA; Chen HW; Tanaka Y; Kawaguchi H; Miyoshi N; Nakagawa T; Fukushima R; Miura N
    Int J Mol Sci; 2019 Sep; 20(19):. PubMed ID: 31569419
    [TBL] [Abstract][Full Text] [Related]  

  • 26. MicroRNA and Messenger RNA Expression Profiles in Canine Mammary Gland Tumor.
    Kim EP; Jang G; Kim JW; Kim SW; Chung H; Yang YJ; Kim WH; Kim GA
    Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768939
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Two GEO MicroRNA Expression Profile Based High-Throughput Screen to Identify MicroRNA-31-3p Regulating Growth of Medullary Thyroid Carcinoma Cell by Targeting RASA2.
    Jiang M; Shi X; Zhu H; Wei W; Li J
    Med Sci Monit; 2019 Jul; 25():5170-5180. PubMed ID: 31298226
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bioinformatic analysis of peripheral blood miRNA of breast cancer patients in relation with anthracycline cardiotoxicity.
    Yadi W; Shurui C; Tong Z; Suxian C; Qing T; Dongning H
    BMC Cardiovasc Disord; 2020 Feb; 20(1):43. PubMed ID: 32013934
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification of differentially expressed miRNAs in serum extracellular vesicles (EVs) of Kazakh sheep at early pregnancy.
    Sun Y; Xu M; Gao R; Xie S; Sun X; He J; Chen X; Li Q; Lu S; Yang M; Li M; Yang H; Huang T; Sun J
    Reprod Domest Anim; 2021 May; 56(5):713-724. PubMed ID: 33547667
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Circulating miRNA Expression Profiling and Target Prediction in Patients Receiving Dexmedetomidine.
    Yang X; Chen H; Chen Y; Birnbaum Y; Liang R; Ye Y; Qian J
    Cell Physiol Biochem; 2018; 50(2):552-568. PubMed ID: 30308506
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Altered miRNA and mRNA Expression in Sika Deer Skeletal Muscle with Age.
    Jia B; Liu Y; Li Q; Zhang J; Ge C; Wang G; Chen G; Liu D; Yang F
    Genes (Basel); 2020 Feb; 11(2):. PubMed ID: 32041309
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comprehensive upstream and downstream regulatory analyses identify miR-675-3p as a potential prognostic biomarker in melanoma.
    Zhao CC; Guo H; Wang Y; Li JH
    Hum Cell; 2021 Mar; 34(2):654-666. PubMed ID: 33400243
    [TBL] [Abstract][Full Text] [Related]  

  • 33. An integrated deep sequencing analysis of microRNAs in transplanted corneas.
    Lu X; Wu J; Ma M; Wu X; Wen J; Yu J
    Mol Immunol; 2018 Sep; 101():429-439. PubMed ID: 30096582
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification of Dysregulated microRNAs in Glioma Using RNA-sequencing.
    Liu C; Ge YY; Xie XX; Luo B; Shen N; Liao XS; Bi SQ; Xu T; Xiao SW; Zhang QM
    Curr Med Sci; 2021 Apr; 41(2):356-367. PubMed ID: 33877554
    [TBL] [Abstract][Full Text] [Related]  

  • 35. MicroRNA Expression Profiling in Clear Cell Renal Cell Carcinoma: Identification and Functional Validation of Key miRNAs.
    He H; Wang L; Zhou W; Zhang Z; Wang L; Xu S; Wang D; Dong J; Tang C; Tang H; Yi X; Ge J
    PLoS One; 2015; 10(5):e0125672. PubMed ID: 25938468
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Characterization of miRNA profiles in the mammary tissue of dairy cattle in response to heat stress.
    Li Q; Yang C; Du J; Zhang B; He Y; Hu Q; Li M; Zhang Y; Wang C; Zhong J
    BMC Genomics; 2018 Dec; 19(1):975. PubMed ID: 30593264
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Screening of Target Genes and Regulatory Function of miRNAs as Prognostic Indicators for Prostate Cancer.
    Xiaoli Z; Yawei W; Lianna L; Haifeng L; Hui Z
    Med Sci Monit; 2015 Dec; 21():3748-59. PubMed ID: 26628405
    [TBL] [Abstract][Full Text] [Related]  

  • 38. MicroRNA expression profiles in familial hypertrophic cardiomyopathy with myosin-binding protein C3 (MYBPC3) gene mutations.
    Lin LR; Hu XQ; Lu LH; Dai JZ; Lin NN; Wang RH; Xie ZX; Chen XM
    BMC Cardiovasc Disord; 2022 Jun; 22(1):278. PubMed ID: 35717150
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Analysis of microRNA expression in canine mammary cancer stem-like cells indicates epigenetic regulation of transforming growth factor-beta signaling.
    Rybicka A; Mucha J; Majchrzak K; Taciak B; Hellmen E; Motyl T; Krol M
    J Physiol Pharmacol; 2015 Feb; 66(1):29-37. PubMed ID: 25716962
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Downregulation of circulating miR 802-5p and miR 194-5p and upregulation of brain MEF2C along breast cancer brain metastasization.
    Sereno M; Haskó J; Molnár K; Medina SJ; Reisz Z; Malhó R; Videira M; Tiszlavicz L; Booth SA; Wilhelm I; Krizbai IA; Brito MA
    Mol Oncol; 2020 Mar; 14(3):520-538. PubMed ID: 31930767
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.